Karrie Wong, PhD

Lab Head/Investigator II
Exploratory Immuno-Oncology
Novartis Institutes for Biomedical Research (NIBR)







Karrie Wong, PhD, is an immunologist with over 10 years of research experience in areas of cancer immunology and immunotherapy. She received her PhD from the University of Toronto, where she explored the role of CD200 in immunomodulation in the context of cancer and as a therapeutic target for Chronic Lymphocytic Leukemia. Upon completing her PhD, Karrie joined Dr. Glenn Dranoff’s laboratory at Dana Farber Cancer institute as a postdoctoral fellow and investigated molecular targets for myeloid cell immunosuppression. Karrie joined the newly formed Exploratory Immuno-Oncology (IO) department at NIBR in 2015 as a research investigator. Currently, she is a Lab Head at NIBR leading exploratory research projects in IO space. Her research interest includes cancer vaccine and immune-metabolism.